Improved Use of Faecal Immunochemical Tests for Haemoglobin in the Scottish Bowel Screening Programme

Overview

Journal J Med Screen

Specialty Public Health

Date 2023 May 25

PMID 37229658

Authors

Jayne Digby

Callum G Fraser

Gavin Clark

Craig Mowat

Judith A Strachan

Robert Jc Steele

Affiliations

Soon will be listed here.

Abstract

Objectives: This study aimed to develop a risk-scoring model in the Scottish Bowel Screening Programme incorporating faecal haemoglobin concentration with other risk factors for colorectal cancer.

Methods: Data were collected for all individuals invited to participate in the Scottish Bowel Screening Programme between November 2017 and March 2018 including faecal haemoglobin concentration, age, sex, National Health Service Board, socioeconomic status, and screening history. Linkage with The Scottish Cancer Registry identified all screening participants diagnosed with colorectal cancer. Logistic regression was performed to identify which factors demonstrated significant association with colorectal cancer and could be used in the development of a risk-scoring model.

Results: Of 232,076 screening participants, 427 had colorectal cancer: 286 diagnosed following a screening colonoscopy and 141 arising after a negative screening test result giving an interval cancer proportion of 33.0%. Only faecal haemoglobin concentration and age showed a statistically significant association with colorectal cancer. Interval cancer proportion increased with age and was higher in women (38.1%) than men (27.5%). If positivity in women were mirrored in men at each age quintile interval cancer proportion would still have remained higher in women (33.2%). Moreover, an additional 1201 colonoscopies would be required to detect 11 colorectal cancers.

Conclusions: Development of a risk scoring model using early data from the Scottish Bowel Screening Programme was not feasible due to most variables showing insignificant association with colorectal cancer. Tailoring the faecal haemoglobin concentration threshold according to age could help to diminish some of the disparity in interval cancer proportion between women and men. Strategies to achieve sex equality using faecal haemoglobin concentration thresholds depend considerably on which variable is selected for equivalency and this requires further exploration.

Citing Articles

Interval cancer risk after the upper age limit of screening has been reached: Informing risk stratification in FIT-based colorectal cancer screening.

van Stigt B, Lansdorp-Vogelaar I, Spaander M, van Vuuren A, Dekker E, van Kemenade F Int J Cancer. 2024; 156(9):1783-1790.

PMID: 39697047 PMC: 11887016. DOI: 10.1002/ijc.35294.

References

Hewitson P, Glasziou P, Watson E, Towler B, Irwig L . Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008; 103(6):1541-9. DOI: 10.1111/j.1572-0241.2008.01875.x. View

Cooper J, Parsons N, Stinton C, Mathews C, Smith S, Halloran S . Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model. Br J Cancer. 2017; 118(2):285-293. PMC: 5785737. DOI: 10.1038/bjc.2017.375. View

Young G, Symonds E, Allison J, Cole S, Fraser C, Halloran S . Advances in Fecal Occult Blood Tests: the FIT revolution. Dig Dis Sci. 2014; 60(3):609-22. PMC: 4366567. DOI: 10.1007/s10620-014-3445-3. View

Clark G, Steele R, Fraser C . Strategies to minimise the current disadvantages experienced by women in faecal immunochemical test-based colorectal cancer screening. Clin Chem Lab Med. 2022; 60(10):1496-1505. DOI: 10.1515/cclm-2022-0583. View

Clark G, Strachan J, McPherson A, Digby J, Mowat C, Steele R . Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies. Clin Chem Lab Med. 2020; 58(12):2073-2080. DOI: 10.1515/cclm-2020-0268. View

Benton S, Piggott C, Zahoor Z, ODriscoll S, Fraser C, DSouza N . A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems. Clin Chem Lab Med. 2022; 60(8):1278-1286. DOI: 10.1515/cclm-2021-1248. View

Quyn A, Fraser C, Stanners G, Carey F, Rees C, Moores B . Scottish Bowel Screening Programme colonoscopy quality - scope for improvement?. Colorectal Dis. 2018; 20(9):O277-O283. DOI: 10.1111/codi.14281. View

Sarkeala T, Farkkila M, Anttila A, Hyoty M, Kairaluoma M, Rautio T . Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland. BMJ Open. 2021; 11(2):e046667. PMC: 7871693. DOI: 10.1136/bmjopen-2020-046667. View

Digby J, McDonald P, Strachan J, Libby G, Steele R, Fraser C . Deprivation and faecal haemoglobin: implications for bowel cancer screening. J Med Screen. 2014; 21(2):95-7. DOI: 10.1177/0969141314535388. View

10.

White A, Ironmonger L, Steele R, Ormiston-Smith N, Crawford C, Seims A . A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer. 2018; 18(1):906. PMC: 6149054. DOI: 10.1186/s12885-018-4786-7. View

11.

Ribbing Wilen H, Saraste D, Blom J . Gender-specific cut-off levels in colorectal cancer screening with fecal immunochemical test: A population-based study of colonoscopy findings and costs. J Med Screen. 2021; 28(4):439-447. DOI: 10.1177/09691413211020035. View

12.

Tran T, Peeters M, Hoeck S, Van Hal G, Janssens S, De Schutter H . Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the "interval cancer" perspective. Br J Cancer. 2022; 126(7):1091-1099. PMC: 8980044. DOI: 10.1038/s41416-021-01694-2. View

13.

Breekveldt E, Toes-Zoutendijk E, van de Schootbrugge-Vandermeer H, de Jonge L, Kooyker A, Spaander M . Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program. Int J Cancer. 2022; 152(8):1536-1546. PMC: 10107864. DOI: 10.1002/ijc.34373. View

14.

Steele R, McDonald P, Digby J, Brownlee L, Strachan J, Libby G . Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity. United European Gastroenterol J. 2014; 1(3):198-205. PMC: 4040749. DOI: 10.1177/2050640613489281. View

15.

McDonald P, Strachan J, Digby J, Steele R, Fraser C . Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer. Clin Chem Lab Med. 2011; 50(5):935-40. DOI: 10.1515/CCLM.2011.815. View

16.

Thomsen M, Pedersen L, Erichsen R, Lash T, Sorensen H, Mikkelsen E . Risk-stratified selection to colonoscopy in FIT colorectal cancer screening: development and temporal validation of a prediction model. Br J Cancer. 2022; 126(8):1229-1235. PMC: 9023517. DOI: 10.1038/s41416-022-01709-6. View

17.

Heinavaara S, Gini A, Sarkeala T, Anttila A, de Koning H, Lansdorp-Vogelaar I . Optimizing screening with faecal immunochemical test for both sexes - Cost-effectiveness analysis from Finland. Prev Med. 2022; 157:106990. DOI: 10.1016/j.ypmed.2022.106990. View

18.

Kortlever T, van der Vlugt M, Dekker E, Bossuyt P . Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screening. Prev Med Rep. 2021; 23:101447. PMC: 8209662. DOI: 10.1016/j.pmedr.2021.101447. View

19.

Clark G, Digby J, Fraser C, Strachan J, Steele R . Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme. J Med Screen. 2021; 29(1):26-31. PMC: 8892068. DOI: 10.1177/09691413211056970. View

20.

Njor S, Rasmussen M, Friis-Hansen L, Andersen B . Varying fecal immunochemical test screening cutoffs by age and gender: a way to increase detection rates and reduce the number of colonoscopies. Gastrointest Endosc. 2021; 95(3):540-549. DOI: 10.1016/j.gie.2021.09.038. View